Putnam Investments’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.71M Sell
1,011,661
-138,090
-12% -$263K ﹤0.01% 685
2023
Q3
$1.37M Sell
1,149,751
-10,700
-0.9% -$16.6K ﹤0.01% 791
2023
Q2
$1.96M Buy
1,160,451
+11,300
+1% +$14.2K ﹤0.01% 737
2023
Q1
$1.2M Sell
1,149,151
-37,800
-3% -$44.9K ﹤0.01% 833
2022
Q4
$926K Sell
1,186,951
-900
-0.1% -$942 ﹤0.01% 846
2022
Q3
$1.78M Buy
1,187,851
+24,293
+2% +$49.9K ﹤0.01% 764
2022
Q2
$2.63M Buy
1,163,558
+326,083
+39% +$945K ﹤0.01% 686
2022
Q1
$2.86M Buy
837,475
+230,375
+38% +$1.25M ﹤0.01% 725
2021
Q4
$4.49M Buy
+607,100
New +$4.41M 0.01% 576

Other funds holding AVAH

Putnam Investments's AVAH Position: Q4 2023 in Review

Putnam Investments reduced its Aveanna Healthcare (AVAH) stake by 12% in Q4 2023, selling an estimated $263K and leaving 1,011,661 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Putnam Investments first reported a position in AVAH in Q4 2021 and has held it in 9 quarters since. The position peaked at $4.49M in Q4 2021. 66 funds tracked by Wall St. Rank hold AVAH as of Q4 2023.

  • Putnam Investments held 1,011,661 shares of Aveanna Healthcare worth $2.71M as of Q4 2023.
  • Putnam Investments sold 138,090 Aveanna Healthcare shares in Q4 2023, an estimated $263K.
  • Aveanna Healthcare made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #685 holding.
  • Putnam Investments first reported a position in Aveanna Healthcare in Q4 2021 and has held it in 9 quarters since.
  • Putnam Investments's Aveanna Healthcare position peaked at $4.49M in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.